We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
Read MoreHide Full Article
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported fourth-quarter fiscal 2019 results, wherein the top and the bottom line surpassed the Zacks Consensus Estimate. This marked the company’s 17th straight earnings beat. Both earnings and sales also improved on a year-over-year basis. Moreover, the company provided upbeat guidance for fiscal 2020.
Procter & Gamble’s core earnings of $1.10 per share improved 17% year over year and outpaced the Zacks Consensus Estimate of $1.06. Meanwhile, currency-neutral core earnings per share (EPS) increased 26%.
The solid quarterly outcome perked up investors' sentiments. Evidently, the stock gained almost 5% during the pre-market trading session. We note that shares of this Zacks Rank #3 (Hold) company have gained 20.2%, outperforming the industry’s 17.1% rally.
The Procter & Gamble Company Price, Consensus and EPS Surprise
Procter & Gamble reported net sales of $17,094 million, which outshined the Zacks Consensus Estimate of $16,873 million. The top line also rose 3.6% year over year. However, the metric was hurt by currency fluctuations to the tune of about 4%.
Organically (excluding impacts of acquisitions, divestitures and foreign exchange), revenues grew 7% driven by a 3% rise in shipment volumes. Further, organic sales benefited 3% from pricing and 2% from favorable mix. Notably, all of the company’s business segments reported organic sales growth.
Health Care and Fabric & Home Care segments registered organic sales growth of 10% each. Moreover, organic sales improved 8% for the Beauty division, 5% for the Baby, Feminine and Family Care, and 4% for the Grooming segment.
Net sales at the Beauty, Health Care, and Fabric & Home Care segments grew 3%, 13% and 5%, respectively. Meanwhile, sales improved 1% at Baby, Feminine & Family Care, while it declined 3% for the Grooming division.
Margins
In the reported quarter, core gross margin increased 120 basis points (bps) year over year to 48.8%, including nearly 40 bps of adverse impact from foreign currency. On a currency-neutral basis, core gross margin expanded 160 bps backed by gains from productivity savings and pricing. This uptick was partly offset by higher commodity costs, unfavorable product mix, innovation reinvestments and other impacts.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, declined 20 bps to 29.2%. Currency-neutral core SG&A costs decreased 50 bps driven by savings from operating expenses, gain from sales leverage and benefit from sale of real estate. This was partly negated by marketing reinvestments, inflation and capability investment mainly in sales and research and development.
Moreover, core operating margin expanded 130 bps to 19.6%, while currency-neutral core operating profit margin increased 210 bps. Currency headwinds dented core operating margin by 80 bps.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $4,239 million, long-term debt of $20,395 million and total shareholders’ equity of $47,579 million.
Cash flow from operating activities amounted to $15,242 million for the fiscal 2019. Operating cash flow for the fiscal fourth quarter was $4.2 billion and free cash flow productivity was $3.3 billion.
Furthermore, the company returned nearly $12.5 billion to its shareholders through dividend payments worth $7.5 billion and share buybacks of roughly $5 billion on fiscal 2019.
For fiscal 2020, the company expects adjusted free cash flow productivity of 90%. It anticipates paying out more than $7.5 billion in dividends and repurchase $6-$8 billion of common shares in fiscal 2020.
Fiscal 2020 Guidance
After the robust results, Procter & Gamble outlined its view for fiscal 2020. The company projects all-in sales growth in the range of 3-4%, including an adverse impact from foreign currency and a modest gain from acquisitions and divestitures. Organic sales for the fiscal year are estimated to increase 3%-4%.
Moreover, the company projects core EPS growth of 4-9% for fiscal 2020 compared with fiscal 2019 core earnings of $4.52 per share. It expects commodities, foreign exchange, transportation and tariffs to modestly aid earnings growth in fiscal 2020. The Zacks Consensus Estimate for earnings is pegged at $4.74 per share.
Colgate-Palmolive Company (CL - Free Report) , also a Zacks Rank #2 stock, has an expected long-term earnings growth rate of 5.4%.
The Estee Lauder Companies Inc. (EL - Free Report) carries a Zacks Rank #2 at present and has an expected long-term earnings growth rate of 13%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported fourth-quarter fiscal 2019 results, wherein the top and the bottom line surpassed the Zacks Consensus Estimate. This marked the company’s 17th straight earnings beat. Both earnings and sales also improved on a year-over-year basis. Moreover, the company provided upbeat guidance for fiscal 2020.
Procter & Gamble’s core earnings of $1.10 per share improved 17% year over year and outpaced the Zacks Consensus Estimate of $1.06. Meanwhile, currency-neutral core earnings per share (EPS) increased 26%.
The solid quarterly outcome perked up investors' sentiments. Evidently, the stock gained almost 5% during the pre-market trading session. We note that shares of this Zacks Rank #3 (Hold) company have gained 20.2%, outperforming the industry’s 17.1% rally.
The Procter & Gamble Company Price, Consensus and EPS Surprise
The Procter & Gamble Company price-consensus-eps-surprise-chart | The Procter & Gamble Company Quote
Sales in Detail
Procter & Gamble reported net sales of $17,094 million, which outshined the Zacks Consensus Estimate of $16,873 million. The top line also rose 3.6% year over year. However, the metric was hurt by currency fluctuations to the tune of about 4%.
Organically (excluding impacts of acquisitions, divestitures and foreign exchange), revenues grew 7% driven by a 3% rise in shipment volumes. Further, organic sales benefited 3% from pricing and 2% from favorable mix. Notably, all of the company’s business segments reported organic sales growth.
Health Care and Fabric & Home Care segments registered organic sales growth of 10% each. Moreover, organic sales improved 8% for the Beauty division, 5% for the Baby, Feminine and Family Care, and 4% for the Grooming segment.
Net sales at the Beauty, Health Care, and Fabric & Home Care segments grew 3%, 13% and 5%, respectively. Meanwhile, sales improved 1% at Baby, Feminine & Family Care, while it declined 3% for the Grooming division.
Margins
In the reported quarter, core gross margin increased 120 basis points (bps) year over year to 48.8%, including nearly 40 bps of adverse impact from foreign currency. On a currency-neutral basis, core gross margin expanded 160 bps backed by gains from productivity savings and pricing. This uptick was partly offset by higher commodity costs, unfavorable product mix, innovation reinvestments and other impacts.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, declined 20 bps to 29.2%. Currency-neutral core SG&A costs decreased 50 bps driven by savings from operating expenses, gain from sales leverage and benefit from sale of real estate. This was partly negated by marketing reinvestments, inflation and capability investment mainly in sales and research and development.
Moreover, core operating margin expanded 130 bps to 19.6%, while currency-neutral core operating profit margin increased 210 bps. Currency headwinds dented core operating margin by 80 bps.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $4,239 million, long-term debt of $20,395 million and total shareholders’ equity of $47,579 million.
Cash flow from operating activities amounted to $15,242 million for the fiscal 2019. Operating cash flow for the fiscal fourth quarter was $4.2 billion and free cash flow productivity was $3.3 billion.
Furthermore, the company returned nearly $12.5 billion to its shareholders through dividend payments worth $7.5 billion and share buybacks of roughly $5 billion on fiscal 2019.
For fiscal 2020, the company expects adjusted free cash flow productivity of 90%. It anticipates paying out more than $7.5 billion in dividends and repurchase $6-$8 billion of common shares in fiscal 2020.
Fiscal 2020 Guidance
After the robust results, Procter & Gamble outlined its view for fiscal 2020. The company projects all-in sales growth in the range of 3-4%, including an adverse impact from foreign currency and a modest gain from acquisitions and divestitures. Organic sales for the fiscal year are estimated to increase 3%-4%.
Moreover, the company projects core EPS growth of 4-9% for fiscal 2020 compared with fiscal 2019 core earnings of $4.52 per share. It expects commodities, foreign exchange, transportation and tariffs to modestly aid earnings growth in fiscal 2020. The Zacks Consensus Estimate for earnings is pegged at $4.74 per share.
3 Stocks to Watch
Church & Dwight Co., Inc. (CHD - Free Report) has an expected long-term earnings growth rate of 8.6%. Moreover, it currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Colgate-Palmolive Company (CL - Free Report) , also a Zacks Rank #2 stock, has an expected long-term earnings growth rate of 5.4%.
The Estee Lauder Companies Inc. (EL - Free Report) carries a Zacks Rank #2 at present and has an expected long-term earnings growth rate of 13%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>